Channel:  Aligning Science Across Parkinson's (ASAP)

479 Articles

Most recent first Previous |  Page 6: Articles 51-60  | Next

Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons
Chen, C., He, Q., Tombesi, G., Napier, E., Jaconelli, M., Moreno-Ramos, O., Serio, H., Naaldijk, Y., Promes, V., Schneeweis, A., Quinn, K., Nasios, C., Greggio, E., Kozorovitskiy, Y., Arango, D., Khan, A. R., Alessi, D. R., Dombeck, D. A., Hilfiker, S., Awatramani, R., Parisiadou, L.
10.1101/2025.08.28.672006 — Posted: 2025-09-03
The LRRK2 p.A419V variant associates with risk of Parkinson disease in the East Asian population and an evaluation on age of onset
Lim, K. S., Perinan, M. T., Chew, E. G. Y., Lee, P. S., Akcimen, F., Lim, J. L., Koretsky, M. J., Funayama, M., Yoshino, H., Hattori, N., Kaiyrzhanov, R., Houlden, H., Isayan, M., Tay, Y. W., Toh, T. S., Lit, L.-C., Khairul Anuar, A. N., Ding, H. X., Screven, L., Mohamed Ibrahim, N., Lin, C.-H., Kim, H.-J., Lee, J.-Y., Chung, S. J., Foo, J. N., Tan, E.-K., Lim, S.-Y., Tan, A. H., Bandres Ciga, S., Ahmad-Annuar, A., Global Parkinson's Genetics Program (GP2)
10.1101/2025.08.28.25333987 — Posted: 2025-09-02
Increased serum Neurofilament light chain levels in Parkinson's Disease patients carrying the p.A53T SNCA mutation: Data from the PPMI study
Papagiannakis, N., Simitsi, A. M., Koros, C., Stefanis, L., The Parkinson's Progression Markers Initiative
10.1101/2025.08.28.25334674 — Posted: 2025-08-29
Microglial activation and alpha-synuclein oligomers drive the early inflammatory phase of Parkinson's disease
Evans, J. R., Grant-Peters, M., Beckwith, J. S., Toomey, C. E., Popovic, R., Breiter, J. C., Brenton, J. W., Fairbrother-Browne, A., Strohbuecker, S., Lachica, J., Rodriguez-Lopez, M., Brock, E. E., Fu, B., Nahidiazar, L., Lopez-Garcia, P., Ferguson, R., Saleeb, R. S., Lucas-Clarke, H., Penverne, A., D'Sa, K., Pang, C. W., Horrocks, M. H., Vendruscolo, M., Wood, N., Lee, S. F., Ryten, M., Gandhi, S.
10.1101/2025.08.25.671921 — Posted: 2025-08-28
LRRK2G2019S acts as a dominant interfering mutant in the context of iron overload
Goldman, A., Nguyen, M., Lanoix, J., Fahmy, A., Zhong Xu, Y., Schurr, E., Thibault, P., Desjardins, M., McBride, H.
10.1101/2025.08.25.672135 — Posted: 2025-08-25
TMEM175, SCARB2 and CTSB associations with Parkinson's disease risk across populations.
Sun, W., Schulte, C., Gasser, T., Tan, M., The Global Parkinson's Genetics Program (GP2)
10.1101/2025.08.17.25333823 — Posted: 2025-08-25
Integrated Representations of Threat and Controllability in the Lateral Frontal Pole
Stasiak, J. E., Wang, J., Dundon, N. M., Rizor, E. J., Villanueva, C. M., Barandon, P. L., Grafton, S. T., Lapate, R. C.
10.1101/2025.08.24.671754 — Posted: 2025-08-24
Structural basis for binding of RILPL1 to TMEM55B reveals a lysosomal platform for adaptor assembly through a conserved TBM motif
Waschbuesch, D., Pal, P., Nirujogi, R. S., Cavin, M., Singh, J., Alessi, D. R., Khan, A. R.
10.1101/2025.08.19.670962 — Posted: 2025-08-24
α-Synuclein driven cell susceptibility in Parkinson's disease
Breiter, J. C., Beckwith, J. S., Brock, E. E., Lachica, J., Toomey, C. E., Fu, B., Ryten, M., Weiss, L. E., Wood, N. W., Gandhi, S., Vendruscolo, M., Lee, S. F.
10.1101/2025.08.19.670819 — Posted: 2025-08-23
Towards Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale
Fan, Z., Searle, G. E., Rizzo, G., Albani, J., Cella, P. A., Comley, R. A., Klein, G., Passamonti, L., Salinas, C. A., Schwarz, A. J., Iaccarino, L., Tamagnan, G., Eberling, J. L., Marek, K., Seibyl, J. P., Gunn, R. N.
10.1101/2025.08.19.25333801 — Posted: 2025-08-21

RSS  Channel RSS